Clinical Trial: HRS-4642 Combination With Other Antitumor Therapies in Patients With Solid Tumors

U.S., Dec. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07296341) titled 'HRS-4642 Combination With Other Antitumor Therapies in Patients With Solid Tumors' on Dec. 09.

Brief Summary: This study is a randomized, open-label, multicenter Phase II clinical trial designed to evaluate the Safety, Tolerability and Preliminary Efficacy of HRS-4642 Combination with Other Antitumor Therapies in Patients with Solid Tumors

Study Start Date: Dec., 2025

Study Type: INTERVENTIONAL

Condition: Locally Advanced or Metastatic Pancreatic Cancer With

Intervention: DRUG: HRS-4642;Adebrelimab Injection; nab-paclitaxel; gemcitabine

HRS-4642 combination with Adebrelimab Injection, nab-paclitaxel in combination with gemcit...